Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
History
Technology
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
Loading...
0:00 / 0:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d1/6f/9f/d16f9f26-1982-d745-6aa0-288574c187ca/mza_6348993118871209209.jpg/600x600bb.jpg
Life Sciences 360
Harsh Thakkar
84 episodes
1 month ago
Why Most Healthcare Brands Fail (And How to Fix It) In this episode, Holley Miller, Founder and President of Grey Matter Marketing, reveals why most medtech and life sciences companies fail to connect with their audience—and how to fix that with brand clarity and strategic storytelling. You’ll learn how marketing in regulated industries is evolving, why flashy tactics often fall flat, and how brand equity is built through consistency, credibility, and emotional connection. Holley also share...
Show more...
Life Sciences
Science
RSS
All content for Life Sciences 360 is the property of Harsh Thakkar and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Why Most Healthcare Brands Fail (And How to Fix It) In this episode, Holley Miller, Founder and President of Grey Matter Marketing, reveals why most medtech and life sciences companies fail to connect with their audience—and how to fix that with brand clarity and strategic storytelling. You’ll learn how marketing in regulated industries is evolving, why flashy tactics often fall flat, and how brand equity is built through consistency, credibility, and emotional connection. Holley also share...
Show more...
Life Sciences
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d1/6f/9f/d16f9f26-1982-d745-6aa0-288574c187ca/mza_6348993118871209209.jpg/600x600bb.jpg
Why 55% of Clinical Trials Fail – The Truth About Drug Development
Life Sciences 360
43 minutes
4 months ago
Why 55% of Clinical Trials Fail – The Truth About Drug Development
Have you ever wondered why so many clinical trials fail before reaching the market? In this episode, we dive deep into the hidden challenges of clinical trials with Rob Freishtat, President and Co-Founder of Uncommon Cures and a professor at George Washington University School of Medicine and Health Sciences. Rob shares insider knowledge on why over 55% of clinical trials fail, the high costs of drug development, and how misaligned priorities between researchers, regulators, and sponsors can ...
Life Sciences 360
Why Most Healthcare Brands Fail (And How to Fix It) In this episode, Holley Miller, Founder and President of Grey Matter Marketing, reveals why most medtech and life sciences companies fail to connect with their audience—and how to fix that with brand clarity and strategic storytelling. You’ll learn how marketing in regulated industries is evolving, why flashy tactics often fall flat, and how brand equity is built through consistency, credibility, and emotional connection. Holley also share...